Cobblestone Capital Advisors LLC Merck & Co., Inc. Transaction History

Cobblestone Capital Advisors LLC

$1.71 Billion
Q3 2024

A detailed history of Cobblestone Capital Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cobblestone Capital Advisors LLC holds 37,710 shares of MRK stock, worth $3.67 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

37,710

Previous 37,495 0.57%

Holding current value

$3.67 Million

Previous $4.64 Million 7.74%

% of portfolio

0.25%

Previous 0.29%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $23,897 - $27,728	215 Added 0.57%	37,710 $4.28 Million
Q2 2024 Aug 06, 2024	SELL	$123.8 - $132.96 $139,151 - $149,447	-1,124 Reduced 2.91%	37,495 $4.64 Million
Q1 2024 May 03, 2024	SELL	$113.24 - $131.95 $33,179 - $38,661	-293 Reduced 0.75%	38,619 $5.1 Million
Q4 2023 Feb 09, 2024	BUY	$100.18 - $109.02 $9,416 - $10,247	94 Added 0.24%	38,912 $4.24 Million
Q3 2023 Nov 07, 2023	BUY	$102.95 - $114.33 $12,971 - $14,405	126 Added 0.33%	38,818 $4 Million
Q2 2023 Aug 01, 2023	SELL	$108.61 - $118.38 $107,306 - $116,959	-988 Reduced 2.49%	38,692 $4.46 Million
Q1 2023 May 05, 2023	SELL	$102.94 - $114.86 $105,925 - $118,190	-1,029 Reduced 2.53%	39,680 $4.22 Million
Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $194,554 - $249,444	2,225 Added 5.78%	40,709 $4.52 Million
Q3 2022 Nov 07, 2022	SELL	$84.53 - $94.96 $2,282 - $2,563	-27 Reduced 0.07%	38,484 $3.31 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $51,012 - $57,825	611 Added 1.61%	38,511 $3.51 Million
Q1 2022 Apr 29, 2022	SELL	$73.51 - $82.4 $39,180 - $43,919	-533 Reduced 1.39%	37,900 $3.11 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $242,065 - $303,218	3,349 Added 9.55%	38,433 $2.95 Million
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $137,840 - $151,590	-1,923 Reduced 5.2%	35,084 $2.64 Million
Q2 2021 Aug 05, 2021	SELL	$70.31 - $77.77 $60,818 - $67,271	-865 Reduced 2.28%	37,007 $2.88 Million
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $483,052 - $568,986	-7,015 Reduced 15.63%	37,872 $2.92 Million
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $111,171 - $123,377	1,549 Added 3.57%	44,887 $3.67 Million
Q3 2020 Nov 05, 2020	SELL	$73.18 - $82.95 $804 - $912	-11 Reduced 0.03%	43,338 $3.6 Million
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $21,478 - $24,439	-305 Reduced 0.7%	43,349 $3.35 Million
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $164,419 - $227,892	-2,595 Reduced 5.61%	43,654 $3.36 Million
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $177,658 - $200,466	-2,290 Reduced 4.72%	46,249 $4.21 Million
Q3 2019 Nov 08, 2019	SELL	$76.08 - $82.93 $834,217 - $909,327	-10,965 Reduced 18.43%	48,539 $4.09 Million
Q2 2019 Jul 29, 2019	SELL	$69.84 - $81.59 $8.81 Million - $10.3 Million	-126,172 Reduced 67.95%	59,504 $4.99 Million
Q1 2019 Apr 30, 2019	SELL	$69.58 - $79.36 $70,902 - $80,867	-1,019 Reduced 0.55%	185,676 $15.4 Million
Q4 2018 Jan 30, 2019	SELL	$65.24 - $75.71 $102,622 - $119,091	-1,573 Reduced 0.84%	186,695 $14.3 Million
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $68,535 - $80,593	1,188 Added 0.64%	188,268 $0
Q2 2018 Aug 03, 2018	BUY	$50.83 - $59.72 $39,342 - $46,223	774 Added 0.42%	187,080 $0
Q1 2018 May 02, 2018	SELL	$50.96 - $59.23 $106,506 - $123,790	-2,090 Reduced 1.11%	186,306 $10.1 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $219,436 - $262,031	4,251 Added 2.31%	188,396 $10.6 Million
Q3 2017 Nov 06, 2017	BUY	$58.67 - $63.13 $10.8 Million - $11.6 Million	184,145	184,145 $11.8 Million

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cobblestone Capital Advisors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Cobblestone Capital Advisors LLC with notifications on news.

Account

Cobblestone Capital Advisors LLC Merck & Co., Inc. Transaction History